Long term effect of curcumin in regulation of glycolytic pathway and angiogenesis via modulation of stress activated genes in prevention of cancer

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Das, Laxmidhar ^a   Vinayak, Manjula ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ANTIOXIDANT; COLLAGEN; DRUG COMBINATION; LAMININ; MATRIGEL; PROTEOGLYCAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; DALTON LYMPHOMA; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; ENZYME ACTIVITY; GENE ACTIVITY; GENE SEQUENCE; GLYCOLYSIS; HIF 1 ALPHA; LDH GENE; LIVER CANCER; LYMPHOMA; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; AKR MOUSE; ANIMAL; BIOSYNTHESIS; BIOTRANSFORMATION; COMPARATIVE STUDY; DISEASE COURSE; DRUG COMBINATION; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; LIVER; LYMPHOMA, T-CELL; MALE; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; RANDOMIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; BIOTRANSFORMATION; COLLAGEN; CURCUMIN; DISEASE PROGRESSION; DOWN-REGULATION; DRUG COMBINATIONS; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; LAMININ; LIVER; LYMPHOMA, T-CELL; MALE; MICE; MICE, INBRED AKR; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PROTEOGLYCANS; RANDOM ALLOCATION;

EID: 84903266542     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099583     Document Type: Article

References (52)

1. Yoshiji H, Kuriyama S, Ways DK, Yoshii J, Miyamoto Y, et al. (1999) Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Cancer Research 59(17): 4413-4418. (Pubitemid 29418762)
2. Xu H, Czerwinski P, Hortmann M, Sohn HY, Forstermann U, et al. (2008) Protein kinase C α promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovascular research 78(2): 349-355. (Pubitemid 351556090)
3. Ushio-Fukai M (2006) Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovascular research 71(2): 226-235.
4. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, et al. (2007). Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer research 67(22): 10823-10830. (Pubitemid 350145911)
5. Moon EJ, Sonveaux P, Porporato PE, Danhier P, Gallez B, et al. (2010) NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment. Proceedings of the National Academy of Sciences 107(47): 20477-20482.
6. Nagy MA (2011) HIF-1 is the Commander of Gateways to Cancer. Journal of Cancer Science & Therapy 3(2): 035-040.
7. Seth P, Grant A, Tang J, Vinogradov E, Wang X, et al. (2011) On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate. Neoplasia 13(1): 60.
8. Kim JW, Gao P, Liu YC, Semenza GL, Dang CV (2007) Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Molecular and cellular biology 27(21): 7381-7393. (Pubitemid 350033646)
9. Nishikawa M (2008) Reactive oxygen species in tumor metastasis. Cancer letters 266(1): 53-59.
10. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1): 52-67.
11. Yoon SO, Park SJ, Yun CH, Chung AS (2003) Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. Journal of biochemistry and molecular biology 36(1): 128-137. (Pubitemid 36836264)
12. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, et al. (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. Journal of Biological Chemistry 277(39): 36288-36295.
13. Pathak C, Jaiswal YK, Vinayak M (2007) Possible involvement of queuine in regulation of cell proliferation. Biofactors 29: 159-173. (Pubitemid 350177952)
14. Jaylata Devi B, Sharan RN (2006) Progressive reduction in poly-ADP-ribosylation of histone proteins during Dalton's lymphoma induced ascites tumorigenesis in mice. Cancer letters 238: 135-141. (Pubitemid 43851153)
15. Shishodia S, Chaturvedi MM (2007) Aggarwal BB. Role of curcumin in cancer therapy. Current problems in cancer 31(4): 243-305. (Pubitemid 47077491)
16. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Molecular pharmaceutics 4(6): 807-818.
17. Jacobs DR, Gross MD, Tapsell LC (2009). Food synergy: an operational concept for understanding nutrition. The American journal of clinical nutrition 89(5): 1543S-1548S.
18. Wagner H (2011) Synergy research: approaching a new generation of phytopharmaceuticals. Fitoterapia 82: 34-37.
19. Das L, Vinayak M (2012) Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-kappaB signalling in lymphoma-bearing mice. Bioscience Reports 32(2): 161-170.
20. Goldie H, Felix MD. (1951) Growth characteristics of free tumor cells transformed serially in the peritonial fluid of the mouse. Cancer Res 11: 73-80.
21. Beauchamp C, Fridovich I (1971) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Analytical biochemistry 44(1): 276-287.
22. phox NADPH oxidase. Modulation of activity by calcium and by tobacco mosaic virus infection. Plant Physiology 126(3): 1281-1290.
23. Dietz AA, Lubrano T (1967) Separation and quantitation of lactic dehydrogenase isoenzymes by disc electrophoresis. Analytical biochemistry 20(2): 246-257.
24. Sinha AK (1972) Colorimetric assay of catalase. Analytical biochemistry 47(2): 389-394.
25. Hwang JH, Kim SJ, Kim YH, Noh J R, Gang GT, et al. (2012) Susceptibility to gold nanoparticle-induced hepatotoxicity is enhanced in a mouse model of nonalcoholic steatohepatitis. Toxicology 294(1): 27-35.
26. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL (1985) Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. Journal of Biological Chemistry 260(4): 2493-2500. (Pubitemid 15104858)
27. Vidal-Vanaclocha F (2008) The Prometastatic Microenvironment of the Liver. Cancer Microenvironment 1: 113-129.
28. Van den Eynden GG, Majeed AW, Illemann M, Vermeulen PB, Bird NC, et al. (2013) The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications. Cancer research 73(7): 2031-2043.
29. Das L, Vinayak M (2014) Long term effect of curcumin down regulates expression of TNF-α and IL-6 via modulation of ETS and NF-κB transcription factor in liver of lymphoma bearing mice. Leukemia and Lymphoma. doi:10.3109/10428194.2014.889824
30. Das L, Vinayak M (2014) Curcumin attenuates carcinogenesis by down regulating proinflammatory cytokine interleukin-1 (IL-1α and IL-1β) via modulation of AP-1 and NF-IL6 in lymphoma bearing mice. International Immunopharmacology. doi: http://dx.doi.org/10.1016/j.intimp.2014.02.024
31. Lee HB, Yu MR, Song JS, Ha H (2004) Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney international 65(4): 1170-1179. (Pubitemid 38406955)
32. Mishra S, Vinayak M (2011) Anti-carcinogenic action of ellagic acid mediated via modulation of oxidative stress regulated genes in Dalton lymphoma bearing mice. Leukemia & lymphoma 52(11): 2155-2161.
33. Sharma R, Vinayak M (2012) Antioxidant α-tocopherol checks lymphoma promotion via regulation of expression of protein kinase C-α and c-Myc genes and glycolytic metabolism. Leukemia & lymphoma 53(6): 1203-1210.
34. Sotgia F, Martinez-Outschoorn UE, Lisanti MP (2011) Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?. BMC medicine 9(1): 62.
35. Schrader M, Fahimi HD (2006) Peroxisomes and oxidative stress. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1763(12): 1755-1766.
36. Kobayashi Y, Nishikawa M, Hyoudou K, Yamashita F, Hashida M (2008) Hydrogen peroxide-mediated nuclear factor κB activation in both liver and tumor cells during initial stages of hepatic metastasis. Cancer Science 99(8): 1546-1552.
37. Bravard A, Sabatier L, Hoffschir F, Ricoul M, Luccioni C, Dutrillaux B (1992) SOD2: a new type of tumor-suppressor gene? Int J Cancer 51: 476-480.
38. Behrend L, Mohr A, Dick T, Zwacka RM (2005) Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells. Mol Cell Biol 25:7758-7769. (Pubitemid 41170136)
39. Zhao Y, Xue Y, Oberley TD, Kiningham KK, Lin SM, et al. (2001) Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Research 61(16): 6082-6088. (Pubitemid 32762543)
40. Wu WS, Wu JR (2010) The Role of ROS Signaling in Tumor Progression. In Signal Transduction in Cancer Metastasis (pp. 103-118). Springer Netherlands.
41. Nishikawa M, Hashida M, (2006) Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes, Expert Opin Drug Deliv 3: 355-369. (Pubitemid 43772711)
42. Podar K, Anderson KC (2010) A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways. Cell Cycle 9(9): 1722-1728.
43. Chen JQ, Russo J (2012) Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1826(2): 370-384.
44. Pathak C, Vinayak M (2005) Modulation of lactate dehydrogenase isozymes by modified base queuine. Molecular biology reports 32(3): 191-196. (Pubitemid 41374361)
45. Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer cell 9(6): 425-434. (Pubitemid 43832190)
46. Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, et al. (2007) HIF dependent antitumorigenic effect of antioxidants in vivo. Cancer cell 12(3): 230-238. (Pubitemid 47333417)
47. Shim H, Dolde C, Lewis BC, Wu CS, Dang G, et al. (1997) c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proceedings of the National Academy of Sciences 94(13): 6658-6663. (Pubitemid 27281920)
48. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. Journal of Clinical Investigation 95(4): 1789.
49. Jensen RL, Ragel BT, Whang K, Gillespie D (2006) Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. Journal of Neurooncology 78(3): 233-247. (Pubitemid 44018816)
50. Rundhaug JE (2005) Matrix metalloproteinases and angiogenesis. Journal of cellular and molecular medicine 9(2): 267-285.
51. Klein G, Vellenga E, Fraaije MW, Kamps WA, De Bont ESJM (2004) The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, eg acute leukemia. Critical reviews in oncology/hematology 50(2): 87-100. (Pubitemid 38638736)
52. Yoon SO, Park SJ, Yun CH, Chung AS (2003) Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. Journal of biochemistry and molecular biology, 36(1): 128-137. (Pubitemid 36836264)